Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;15(8):1129-1139.
doi: 10.1111/jdi.14196. Epub 2024 Apr 9.

Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study

Affiliations

Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study

Linan Wang et al. J Diabetes Investig. 2024 Aug.

Abstract

Aims/introduction: Our aim was to investigate the optimal fasting glucose (FPG) range in Chinese older adults with type 2 diabetes, and to clarify whether the optimal range varies according to the control of risk factors.

Materials and methods: The baseline survey for the cohort study began in 2018, with follow up ending in 2022. Our study enrolled 59,030 older diabetes patients with no history of cardiovascular disease (CVD). Participants were divided into nine groups based on their baseline glycemic status. The association between FPG and the risk of adverse outcomes was mainly estimated by multivariate Cox proportional risk models and restricted spline analysis.

Results: During the 4-year follow-up period, a total of 5,637 deaths and 4,904 CVD events occurred. The associations of FPG with mortality and CVD events showed J-shaped curves. Among all-cause deaths, the hazard ratios for FPG ≤4.50 and >11.50 mmol/L were 1.50 (95% confidence interval [CI] 1.31-1.71) and 1.84 (95% CI 1.67-2.02). Among CVD, the hazard ratios for FPG ≤4.50 and >11.50 mmol/L were 1.31 (95% CI 1.13-1.53) and 1.71 (95% CI 1.54-1.89), respectively. The optimal FPG ranges of all-cause mortality and CVD were 5.50-7.50 and 4.50-7.50 mmol/L, respectively. For participants with at least two risk factors, the optimal FPG levels were higher than those with fewer risk factors.

Conclusions: In older Chinese diabetes patients, the FPG ranges related to the minimum death and CVD event rates were 5.50-7.50 and 4.50-7.50 mmol/L, respectively. Patients with more cardiovascular risk factors had higher optimal blood glucose ranges than those with fewer risk factors.

Keywords: Cardiovascular disease; Diabetes patient; Fasting plasma glucose.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Approval of the research protocol: This study was approved by the Ethics Committee of the Wuhan Centers for Disease Control and Prevention (protocol code WHCDCIRB‐K‐2018023).

Informed consent: The written informed consent was obtained from all participants.

Registry and the registration no. of the study/trial: N/A.

Animal studies: N/A.

Figures

Figure 1
Figure 1
Hazard ratios (HRs) and 95% confidence intervals (CIs) for all‐cause mortality and cardiovascular events according to fasting glucose levels at baseline. The solid line represents HR, the shaded area represents 95% CI and the reference value represents the lowest risk. There was a J‐shaped relationship between fasting glucose and the risk of all‐cause death (a) and cardiovascular events (b), with the lowest risk points being 7.27 and 6.94 mmol/L, respectively.
Figure 2
Figure 2
Hazard ratios (HRs) and 95% confidence intervals (CIs) for all‐cause mortality and cardiovascular events according to fasting glucose levels at baseline stratified by uncontrolled risk factors (≥2, <2). The solid line represents HR, the shaded area represents 95% CI and the reference value represents the lowest risk. (a–d) The associated lowest risk points were 7.14, 7.40, 7.03 and 7.43 mmol/L, respectively.

Similar articles

Cited by

References

    1. Sun Y, Ni W, Yuan X, et al. Prevalence, treatment, control of type 2 diabetes and the risk factors among elderly people in Shenzhen: Results from the urban Chinese population. BMC Public Health 2020; 20: 998. - PMC - PubMed
    1. Pei J, Li Y, Yang Y, et al. Prevalence trends and disease burden of diabetes and prediabetes in Chinese adults of Shanghai. J Diabetes 2023; 15: 583–596. - PMC - PubMed
    1. Morrish NJ, Wang SL, Stevens LK, et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44: S14–S21. - PubMed
    1. Singh GM, Danaei G, Farzadfar F, et al. The age‐specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis. PLoS One 2013; 8: e65174. - PMC - PubMed
    1. Fu AZ, Qiu Y, Radican L, et al. Pre‐existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: A matched cohort study. Cardiovasc Diabetol 2010; 9: 15. - PMC - PubMed

MeSH terms